Neuropathology of bipolar disorder

Biological Psychiatry

Volumn 48, Issue 6, 2000, Pages 486-504

  Vawter, Marquis P ^a   Freed, William J ^a   Kleinman, Joel E ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Sect Clin and Exp Neuropsychol   (United States)

Author keywords

Cortex; G protein coupled receptors; Glia; Neuropeptide; Norepinephrine; Serotonin; Synaptic proteins

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARGIPRESSIN; BRAIN MONOAMINE; CELL ADHESION MOLECULE; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HOMOVANILLIC ACID; NERVE CELL ADHESION MOLECULE; NEUROPEPTIDE; NEUROPEPTIDE Y; NORADRENALIN; OXYTOCIN; PHOSPHATIDYLINOSITOL; PROTEIN KINASE C; PROTEIN SUBUNIT; SEROTONIN; SEROTONIN TRANSPORTER; SYNAPSIN; SYNAPTOPHYSIN;

AUTOPSY; BRAIN CELL; BRAIN CORTEX; BRAIN REGION; CELL DENSITY; CELL STRUCTURE; CEREBELLUM; DEPRESSION; GLIA CELL; HUMAN; LIMBIC CORTEX; MANIC DEPRESSIVE PSYCHOSIS; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AUTOPSY; BIPOLAR DISORDER; BRAIN; BRAIN CHEMISTRY; CELL ADHESION MOLECULES; HUMANS; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; SIGNAL TRANSDUCTION;

EID: 0034666042     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00978-1     Document Type: Review

References (148)

1. Aganova E.A., Uranova N.A. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol. 22:1992;59-65.
2. Ali S.O., Denicoff K.D., Altshuler L.L., Hauser P., Li X., Conrad A.J., et al. A preliminary study of the relation of neuropsychological performance to neuroanatomic structures in bipolar disorder. Neuropsychiatry Neuropsychol Behav Neurol. 13:2000;20-28.
3. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Mintz J. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia An MRI study demonstrating neuroanatomic specificity . Arch Gen Psychiatry. 55:1998;663-664.
4. Altshuler L.L., Conrad A., Hauser P., Li X.M., Guze B.H., Denikoff K., et al. Reduction of temporal lobe volume in bipolar disorder A preliminary report of magnetic resonance imaging . Arch Gen Psychiatry. 48:1991;482-483.
5. Arango V., Underwood M.D., Mann J.J. Fewer pigmented neurons in the locus coeruleus of uncomplicated alcoholics. Brain Res. 650:1994;1-8.
6. Arango V., Underwood M.D., Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims Preliminary results . Biol Psychiatry. 39:1996;112-120.
7. Arnold S.E., Hyman B.T., Van Hoesen G.W., Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry. 48:1991;625-632.
8. Baumann B., Danos P., Krell D., Diekmann S., Leschinger A., Stauch R., et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders Preliminary data from a postmortem study . J Neuropsychiatry Clin Neurosci. 11:1999;71-78.
9. Baumann B., Danos P., Krell D., Diekmann S., Wurthmann C., Bielau H., et al. Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord. 54:1999;217-224.
10. Beckmann H., Jakob H. Prenatal disturbances of nerve cell migration in the entorhinal region A common vulnerability factor in functional psychoses? J Neural Transm. 84:1991;155-164.
11. Belmaker R.H., Agam G., van Calker D., Richards M.H., Kofman O. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle Depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients . Neuropsychopharmacology. 19:1998;220-232.
12. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 44:1998;88-97.
13. Bernstein H.G., Krell D., Baumann B., Danos P., Falkai P., Diekmann S., et al. Morphometric studies of the entorhinal cortex in neuropsychiatric patients and control subjects Clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia . Schizophr Res. 33:1998;125-132.
14. Brown E.S., Rush A.J., McEwen B.S. Hippocampal remodeling and damage by corticosteroids Implications for mood disorders . Neuropsychopharmacology. 21:1999;474-484.
15. Bunney W.E., Garland-Bunney B.L. Mechanisms of action of lithium in affective illness Basic and clinical implications . Meltzer H.Y. Psychopharmacology The Third Generation of Progress . 1987;553-565 Raven, New York.
16. Bunney W.E. Jr, Davis J.M. Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry. 13:1965;483-494.
17. Caberlotto L., Hurd Y.L. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport. 10:1999;1747-1750.
18. Cameron H.A., Tanapat P., Gould E. Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neuroscience. 82:1998;349-354.
19. Cameron R., Klein L., Shyjan A.W., Rakic P., Levenson R. Neurons and astroglia express distinct subsets of Na,K-ATPase alpha and beta subunits. Brain Res Mol Brain Res. 21:1994;333-343.
20. Casanova M.F., Kleinman J.E. The neuropathology of schizophrenia A critical assessment of research methodologies . Biol Psychiatry. 27:1990;353-362.
21. Casanova M.F., Zito M., Altshuler L., Weinberger D.R., Kleinman J.E. Normal nucleolar size of entorhinal cortex cells in schizophrenia. Psychiatry Res. 44:1992;79-82.
22. Colin S.F., Chang H.C., Mollner S., Pfeuffer T., Reed R.R., Duman R.S., Nestler E.J. Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proc Natl Acad Sci U S A. 88:1991;10634-10637.
23. Crossin K.L., Tai M.H., Krushel L.A., Mauro V.P., Edelman G.M. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci U S A. 94:1997;2687-2692.
24. Cunningham B.A., Hemperly J.J., Murray B.A., Prediger E.A., Brackenbury R., Edelman G.M. Neural cell adhesion molecule Structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing . Science. 236:1987;799-806.
25. Davies A.M. The neurotrophic hypothesis Where does it stand? Philos Trans R Soc Lond B Biol Sci. 351:1996;389-394.
26. DelBello M.P., Strakowski S.M., Zimmerman M.E., Hawkins J.M., Sax K.W. MRI analysis of the cerebellum in bipolar disorder A pilot study . Neuropsychopharmacology. 21:1999;63-68.
27. Dib K., el Jamali A., Jacquemin C., Correze C. Cyclic AMP regulation of messenger RNA level of the stimulatory GTP-binding protein Gs alpha. Isoproterenol, forskolin and 8-bromoadenosine 3′:5′-cyclic monophosphate increase the level of Gs alpha mRNA in cultured astroglial cells. Eur J Biochem. 219:1994;529-537.
28. Doherty P., Moolenaar C.E., Ashton S.V., Michalides R.J., Walsh F.S. The VASE exon downregulates the neurite growth-promoting activity of NCAM 140. Nature. 356:1992;791-793.
29. Dousa T., Hechter O. Lithium and brain adenyl cyclase. Lancet. 1:1970;834-835.
30. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., Young L.T. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders Effects of diagnosis, suicide, and treatment at the time of death . J Neurochem. 73:1999;1121-1126.
31. Drevets W.C. Functional neuroimaging studies of depression The anatomy of melancholia . Annu Rev Med. 49:1998;341-361.
32. Drevets W.C., Ongur D., Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex Implications for the pathophysiology of familial mood disorders . Mol Psychiatry. 3:1998;190-226.
33. Drevets W.C., Price J.L., Simpson J.R. Jr, Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
34. Eclancher F., Kehrli P., Labourdette G., Sensenbrenner M. Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Brain Res. 737:1996;201-214.
35. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nat Med. 4:1998;1313-1317.
36. Faissner A., Scholze A., Gotz B. Tenascin glycoproteins in developing neural tissues Only decoration? Perspect Dev Neurobiol. 2:1994;53-66.
37. Fields A., Li P.P., Kish S.J., Warsh J.J. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J Neurochem. 73:1999;1704-1710.
38. Forn J., Valdecasas F.G. Effects of lithium on brain adenyl cyclase activity. Biochem Pharmacol. 20:1971;2773-2779.
39. Forster E., Frotscher M. Developmental upregulation of the neural cell adhesion molecule VASE exon in slice cultures of rat hippocampus. Neurosci Lett. 199:1995;167-170.
40. Freed W.J., Vawter M.P., Freed L.M., Webster M.J. Normal tenascin distribution in the hippocampus in schizophrenia. Schizophr Res. 36:1999;71.
41. Friedman E., Wang H.Y. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J Neurochem. 67:1996;1145-1152.
42. Gegelashvili G., Andersson A.M., Schousboe A., Bock E. Cyclic AMP regulates NCAM expression and phosphorylation in cultured mouse astrocytes. Eur J Cell Biol. 62:1993;343-351.
43. Gerner R.H., Yamada T. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res. 238:1982;298-302.
44. Glowinski J., Marin P., Tence M., Stella N., Giaume C., Premont J. Glial receptors and their intervention in astrocyto-astrocytic and astrocyto-neuronal interactions. Glia. 11:1994;201-208.
45. Gold P.W., Goodwin F.K. Vasopressin in affective illness. Lancet. 1:1978;1233-1236.
46. Gomez-Pinilla F., So V., Kesslak J.P. Spatial learning and physical activity contribute to the induction of fibroblast growth factor Neural substrates for increased cognition associated with exercise . Neuroscience. 85:1998;53-61.
47. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biol Psychiatry. 46:1999;1472-1479.
48. Gower H.J., Barton C.H., Elsom V.L., Thompson J., Moore S.E., Dickson G., Walsh F.S. Alternative splicing generates a secreted form of N-CAM in muscle and brain. Cell. 55:1988;955-964.
49. Grebb J.A., Browning M.D. Intraneuronal biochemical signals. Kaplan H.I., Sadock B.J. Comprehensive Textbook of Psychiatry/V. 1989;60-67 Williams & Wilkins, Baltimore. Vol 1.
50. Green A.I., Mooney J.J., Posener J.A., Schildkraut J.J. Mood disorders Biochemical aspects . Kaplan H.I., Sadock B.J. Comprehensive Textbook of Psychiatry/V. 1989;1089-1101 Williams & Wilkins, Baltimore. Vol 1.
51. Guillemin G., Boussin F.D., Le Grand R., Croitoru J., Coffigny H., Dormont D. Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia. 16:1996;71-80.
52. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 122:1999;593-624.
53. Helmkamp C.E., Bigelow L.B., Paltan-Ortiz J.D., Torrey E.F., Kleinman J.E., Herman M.M. Evaluation of superior vermal Purkinje cell placement in mental illness. Biol Psychiatry. 45:1999;1370-1375.
54. Hilfiker S., Pieribone V.A., Czernik A.J., Kao H.T., Augustine G.J., Greengard P. Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci. 354:1999;269-279.
55. Hrdina P., Faludi G., Li Q., Bendotti C., Tekes K., Sotonyi P., Palkovits M. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Mol Psychiatry. 3:1998;411-418.
56. Jeste D.V., Lohr J.B., Goodwin F.K. Neuroanatomical studies of major affective disorders. A review and suggestions for further research. Br J Psychiatry. 153:1988;444-459.
57. Jope R.S., Song L., Li P.P., Young L.T., Kish S.J., Pacheco M.A., Warsh J.J. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem. 66:1996;2402-2409.
58. Jorgensen O.S. SNAP-25 is the major immunoreactive component of the brain-specific D3 protein. Neuroreport. 7:1995;73-76.
59. Jorgensen O.S., Bock E., Bech P., Rafaelsen O.J. Synaptic membrane protein D2 in the cerebrospinal fluid of manic-melancholic patients. Acta Psychiatr Scand. 56:1977;50-56.
60. Jorgensen O.S., Riederer P. Increased synaptic markers in hippocampus of depressed patients. J Neural Transm. 64:1985;55-66.
61. Joyce J.N., Lexow N., Kim S.J., Artymyshyn R., Senzon S., Lawrence D., et al. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain Alterations in limbic regions of schizophrenics . Synapse. 10:1992;228-246.
62. Kiraly S.J., Ancill R.J., Dimitrova G. The relationship of endogenous cortisol to psychiatric disorder A review . Can J Psychiatry. 42:1997;415-420.
63. Kiriike N., Izumiya Y., Nishiwaki S., Maeda Y., Nagata T., Kawakita Y. TRH test and DST in schizoaffective mania, mania, and schizophrenia. Biol Psychiatry. 24:1988;415-422.
64. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci. 17:1997;8451-8458.
65. Kotter K., Klein J. Adrenergic modulation of astroglial phospholipase D activity and cell proliferation. Brain Res. 830:1999;138-145.
66. Krimer L.S., Herman M.M., Saunders R.C., Boyd J.C., Hyde T.M., Carter J.M., et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex. 7:1997;732-739.
67. Krushel L.A., Tai M.H., Cunningham B.A., Edelman G.M., Crossin K.L. Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci U S A. 95:1998;2592-2596.
68. Leake A., Fairbairn A.F., McKeith I.G., Ferrier I.N. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain Neurochemical and clinical correlates . Psychiatry Res. 39:1991;155-165.
69. Lenox R.H., McNamara R.K., Papke R.L., Manji H.K. Neurobiology of lithium An update . J Clin Psychiatry. 59:1998;37-47.
70. Linnet K., Koed K., Wiborg O., Gregersen N. Serotonin depletion decreases serotonin transporter mRNA levels in rat brain. Brain Res. 697:1995;251-253.
71. Liu L., Haines S., Shew R., Akeson R.A. Axon growth is enhanced by NCAM lacking the VASE exon when expressed in either the growth substrate or the growing axon. J Neurosci Res. 35:1993;327-345.
72. Loeber R.T., Sherwood A.R., Renshaw P.F., Cohen B.M., Yurgelun-Todd D.A. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophr Res. 37:1999;81-89.
73. Looney S.W., el-Mallakh R.S. Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness. Depress Anxiety. 5:1997;53-65.
74. Luthi A., Mohajeri H., Schachner M., Laurent J.P. Reduction of hippocampal long-term potentiation in transgenic mice ectopically expressing the neural cell adhesion molecule L1 in astrocytes. J Neurosci Res. 46:1996;1-6.
75. Manji H.K., Moore G.J., Chen G. . Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo A role for neurotrophic and neuroprotective effects in manic depressive illness . J Clin Psychiatry. 9:2000;82-96.
76. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
77. Martin K.C., Kandel E.R. Cell-adhesion molecules, CREB and the formation of new synaptic connections. Neuron. 17:1996;567-570.
78. Mathews R., Li P.P., Young L.T., Kish S.J., Warsh J.J. Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol Psychiatry. 41:1997;649-656.
79. McDonald W.M., Tupler L.A., Marsteller F.A., Figiel G.S., DiSouza S., Nemeroff C.B., Krishnan K.R. Hyperintense lesions on magnetic resonance images in bipolar disorder. Biol Psychiatry. 45:1999;965-971.
80. Meltzer H (1989): Serotonergic dysfunction in depression. Br J Psychiatry Suppl 25-31.
81. Moore G.J., Bebchuk J.M., Parrish J.K., Faulk M.W., Arfken C.L., Strahl-Bevacqua J., Manji H.K. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry. 156:1999;1902-1908.
82. Mori S., Tardito D., Dorigo A., Zanardi R., Smeraldi E., Racagni G., Perez J. Effects of lithium on cAMP-dependent protein kinase in rat brain. Neuropsychopharmacology. 19:1998;233-240.
83. Mynett-Johnson L., Murphy V., McCormack J., Shields D.C., Claffey E., Manley P., McKeon P. Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3). Biol Psychiatry. 44:1998;47-51.
84. Nasrallah H.A., Coffman J.A., Olson S.C. Structural brain-imaging findings in affective disorders An overview . J Neuropsychiatry Clin Neurosci. 1:1989;21-26.
85. Nasrallah H.A., McCalley-Whitters M., Bigelow L.B., Rauscher F.P. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Res. 8:1983;251-260.
86. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
87. Ordway G.A. Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci. 836:1997;233-252.
88. Ordway G.A., Stockmeier C.A., Meltzer H.Y., Overholser J.C., Jaconetta S., Widdowson P.S. Neuropeptide Y in frontal cortex is not altered in major depression. J Neurochem. 65:1995;1646-1650.
89. Ozawa H., Gsell W., Frolich L., Zochling R., Pantucek F., Beckmann H., Riederer P. Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients. J Neural Transm. 94:1993;63-69.
90. Ozawa H., Katamura Y., Hatta S., Saito T., Katada T., Gsell W., et al. Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics. Brain Res. 620:1993;174-179.
91. Pacheco M.A., Jope R.S. Phosphoinositide signaling in human brain. Prog Neurobiol. 50:1996;255-273.
92. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res. 723:1996;37-45.
93. Pazos A., Probst A., Palacios J.M. Beta-adrenoceptor subtypes in the human brain Autoradiographic localization . Brain Res. 358:1985;324-328.
94. Pearlson G.D. Structural and functional brain changes in bipolar disorder A selective review . Schizophr Res. 39:1999;133-140.
95. Perrone-Bizzozero N.I., Sower A.C., Bird E.D., Benowitz L.I., Ivins K.J., Neve R.L. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A. 93:1996;14182-14187.
96. Plenge P., Mellerup E.T., Jorgensen O.S. Lithium treatment regimens induce different changes in [3H]paroxetine binding protein and other rat brain proteins. Psychopharmacology (Berl). 106:1992;131-135.
97. Poltorak M., Frye M.A., Wright R., Hemperly J.J., George M.S., Pazzaglia P.J., et al. Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem. 66:1996;1532-1538.
98. Poltorak M., Khoja I., Hemperly J.J., Williams J.R., el-Mallakh R., Freed W.J. Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia. Exp Neurol. 131:1995;266-272.
99. Poltorak M., Wright R., Hemperly J.J., Torrey E.F., Issa F., Wyatt R.J., Freed W.J. Monozygotic twins discordant for schizophrenia are discordant for N-CAM and L1 in CSF. Brain Res. 751:1997;152-154.
100. Prange A.J. Jr, Wilson I.C., Lynn C.W., Alltop L.B., Stikeleather R.A. L-Tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatry. 30:1974;56-62.
101. Purba J.S., Hoogendijk W.J., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 53:1996;137-143.
102. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
103. Rabinowitz J.E., Rutishauser U., Magnuson T. Targeted mutation of Ncam to produce a secreted molecule results in a dominant embryonic lethality. Proc Natl Acad Sci U S A. 93:1996;6421-6424.
104. Rahman S., Li P.P., Young L.T., Kofman O., Kish S.J., Warsh J.J. Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem. 68:1997;297-304.
105. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann N Y Acad Sci. 836:1997;253-268.
106. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 45:1999;1085-1098.
107. Ressler K.J., Nemeroff C.B. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry. 46:1999;1219-1233.
108. Reyes A.A., Schulte S.V., Small S., Akeson R. Distinct NCAM splicing events are differentially regulated during rat brain development. Brain Res Mol Brain Res. 17:1993;201-211.
109. Reznikoff G.A., Manaker S., Rhodes C.H., Winokur A., Rainbow T.C. Localization and quantification of beta-adrenergic receptors in human brain. Neurology. 36:1986;1067-1073.
110. Ronn L.C., Hartz B.P., Bock E. The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system. Exp Gerontol. 33:1998;853-864.
111. Rose A.M., Mellett B.J., Valdes R. Jr, Kleinman J.E., Herman M.M., Li R., el-Mallakh R.S. Alpha 2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry. 44:1998;892-897.
112. Rush A.J., Giles D.E., Schlesser M.A., Orsulak P.J., Parker C.R. Jr, Weissenburger J.E., et al. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry. 57:1996;470-484.
113. Schildkraut J.J. The catecholamine hypothesis of affective disorders A review of supporting evidence . Am J Psychiatry. 122:1965;509.
114. Schramm M., Falkai P., Feldmann N., Knable M.B., Bayer T.A. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia. Neurosci Lett. 257:1998;65-68.
115. Seckl J.R., French K.L., O'Donnell D., Meaney M.J., Nair N.P., Yates C.M., Fink G. Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease. Brain Res Mol Brain Res. 18:1993;239-245.
116. Sherman W.R., Munsell L.Y., Gish B.G., Honchar M.P. Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis. J Neurochem. 44:1985;798-807.
117. Shimon H., Agam G., Belmaker R.H., Hyde T.M., Kleinman J.E. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry. 154:1997;1148-1150.
118. Silver J. Inhibitory molecules in development and regeneration. J Neurol. 242:1994;S22-S24.
119. Singh M.M. A unifying hypothesis on the biochemical basis of affective disorder. Psychiatr Q. 44:1970;706-724.
120. Snider RM, Fisher SK, Agranoff BW (1987): Inositide-linked second messengers in the central nervous system. In: Meltzer HY, editor. Psychopharmacology: The Third Generation of Progress. Baltimore: Williams & Wilkins, 317-324.©
121. Soares J.C., Mann J.J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry. 41:1997;86-106.
122. Sower A.C., Bird E.D., Perrone-Bizzozero N.I. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method. Mol Chem Neuropathol. 24:1995;1-11.
123. Spleiss O., van Calker D., Scharer L., Adamovic K., Berger M., Gebicke-Haerter P.J. Abnormal G protein alpha(s)- and alpha(i2)-subunit mRNA expression in bipolar affective disorder. Mol Psychiatry. 3:1998;512-520.
124. Strakowski S.M., DelBello M.P., Sax K.W., Zimmerman M.E., Shear P.K., Hawkins J.M., Larson E.R. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry. 56:1999;254-260.
125. Sugita Y., Zhao B., Shankar P., Dunbar C.E., Doren S., Young H.A., Schwartz J.P. CNS interleukin-3 (IL-3) expression and neurological syndrome in antisense-IL-3 transgenic mice. J Neuropathol Exp Neurol. 58:1999;480-488.
126. Svoboda K.R., Adams C.E., Lupica C.R. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J Neurosci. 19:1999;85-95.
127. Swayze V.W., Andreasen N.C., Alliger R.J., Yuh W.T., Ehrhardt J.C. Subcortical and temporal structures in affective disorder and schizophrenia A magnetic resonance imaging study . Biol Psychiatry. 31:1992;221-240.
128. Thompson P.M., Rosenberger C., Qualls C. CSF SNAP-25 in schizophrenia and bipolar illness. Neuropsychopharmacology. 21:1999;717-722.
129. van Kammen D.P., Poltorak M., Kelley M.E., Yao J.K., Gurklis J.A., Peters J.L., et al. Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia. Biol Psychiatry. 43:1998;680-686.
130. Vawter M.P., Cannon-Spoor H.E., Hemperly J.J., Hyde T.M., VanderPutten D.M., Kleinman J.E., Freed W.J. Abnormal expression of cell recognition molecules in schizophrenia. Exp Neurol. 149:1998;424-432.
131. Vawter M.P., Hemperly J.J., Hyde T.M., Bachus S.E., VanderPutten D.M., Howard A.L., et al. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia. Exp Neurol. 154:1998;1-11.
132. Vawter M.P., Howard A.L., Hyde T.M., Kleinman J.E., Freed W.J. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry. 4:1999;467-475.
133. Vawter M.P., Frye M.A., Hemperly J.J., VanderPutten D.M., Usen N., Doherty P., et al. Elevated concentration of N-CAM VASE isoforms in schizophrenia. J Psychiatr Res. 34:2000;25-34.
134. Verebey K., Volavka J., Clouet D. Endorphins in psychiatry An overview and a hypothesis . Arch Gen Psychiatry. 35:1978;877-888.
135. Videbech P. MRI findings in patients with affective disorder A meta-analysis . Acta Psychiatr Scand. 96:1997;157-168.
136. Walsh F.S., Furness J., Moore S.E., Ashton S., Doherty P. Use of the neural cell adhesion molecule VASE exon by neurons is associated with a specific down-regulation of neural cell adhesion molecule-dependent neurite outgrowth in the developing cerebellum and hippocampus. J Neurochem. 59:1992;1959-1962.
137. Wang H.Y., Friedman E. Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology (Berl). 99:1989;213-218.
138. Wang H.Y., Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry. 40:1996;568-575.
139. Webster M.J., Vawter M.P., Freed W.J. Immunohistochemical localization of the cell adhesion molecules Thy-1 and L1 in the human prefrontal cortex patients with schizophrenia, bipolar disorder, and depression. Mol Psychiatry. 4:1999;46-52.
140. Whitaker-Azmitia P.M., Azmitia E.C. Astroglial 5-HT1a receptors and S-100 beta in development and plasticity. Perspect Dev Neurobiol. 2:1994;233-238.
141. Young E.A., Vazquez D. Hypercortisolemia, hippocampal glucocorticoid receptors, and fast feedback. Mol Psychiatry. 1:1996;149-159.
142. Young L.T., Asghari V., Li P.P., Kish S.J., Fahnestock M., Warsh J.J. Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. Brain Res Mol Brain Res. 42:1996;45-50.
143. Young L.T., Li P.P., Kamble A., Siu K.P., Warsh J.J. Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry. 151:1994;594-596.
144. Young L.T., Li P.P., Kish S.J., Siu K.P., Kamble A., Hornykiewicz O., Warsh J.J. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem. 61:1993;890-898.
145. Young L.T., Li P.P., Kish S.J., Siu K.P., Warsh J.J. Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. Brain Res. 553:1991;323-326.
146. Young L.T., Li P.P., Kish S.J., Warsh J.J. Cerebral cortex beta-adrenoceptor binding in bipolar affective disorder. J Affect Disord. 30:1994;89-92.
147. Young L.T., Warsh J.J., Kish S.J., Shannak K., Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry. 35:1994;121-127.
148. Zisook S., Janowsky D.S., Overall J.E., Risch S.C. The dexamethasone suppression test and unipolar/bipolar distinctions. J Clin Psychiatry. 46:1985;461-465.